✦ LIBER ✦

KIT and FLT3 receptor tyrosine kinase mutations in acute myeloid leukemia with favorable cytogenetics: Two novel mutations and selective occurrence in leukemia subtypes and age groups

✍ Scribed by Narongrit Sritana; Chirayu U. Auewarakul

Book ID: 113956588
Publisher: Elsevier Science
Year: 2008
Tongue: English
Weight: 863 KB
Volume: 85
Category: Article
ISSN: 0014-4800
DOI: 10.1016/j.yexmp.2008.09.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment with FLT3 inhibitor in patient

Treatment with FLT3 inhibitor in patients with FLT3 -mutated acute myeloid leukemia is associated with development of secondary FLT3 -tyrosine kinase domain mutations

✍ Alvarado, Yesid; Kantarjian, Hagop M.; Luthra, Rajyalakshmi; Ravandi, Farhad; Bo 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB

CEBPA single mutation can be a possible

CEBPA single mutation can be a possible favorable prognostic indicator in NPM1 and FLT3-ITD wild-type acute myeloid leukemia patients with intermediate cytogenetic risk

✍ Park, Sang Hyuk; Chi, Hyun-Sook; Cho, Young-Uk; Jang, Seongsoo; Park, Chan-Jeoun 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 758 KB

Internal tandem duplication and Asp835 m

Internal tandem duplication and Asp835 mutations of the FMS-like tyrosine kinase 3 (FLT3) gene in acute promyelocytic leukemia : Correlation with molecular subtypes of PML/RARα and clinical features

✍ Lee-Yung Shih; Ming-Chung Kuo; Der-Cherng Liang; Chein-Fuang Huang; Tung-Liang L 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 2 views

## Abstract ## BACKGROUND The clinical relevance of mutations of the __FMS__‐like tyrosine kinase 3 (__FLT3__) gene in specific cytogenetic subgroups is not clear. The authors examined internal tandem duplication (ITD) and Asp835 mutations of __FLT3__ in patients with acute promyelocytic leukemia

Analysis of FLT3 length mutations in 100

Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease

✍ Schnittger, S. 📂 Article 📅 2002 🏛 American Society of Hematology 🌐 English ⚖ 252 KB